JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bethell, G. S.
Right arrow Articles by Hearn, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bethell, G. S.
Right arrow Articles by Hearn, M. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

JBC, Vol. 254, Issue 8, 2572-2574, Apr, 1979

A novel method of activation of cross-linked agaroses with 1,1'-carbonyldiimidazole which gives a matrix for affinity chromatography devoid of additional charged groups

G. S. Bethell, J. S. Ayers, W. S. Hancock and M. T. Hearn

1,1'-Carbonyldiimidazole, a carbonylating reagent, has been shown to be suitable for the activation of cross-linked agaroses for affinity chromatography. The activated matrix (an imidazolyl carbamate) is relatively stable to hydrolysis but smoothly reacts with N-nucleophiles such as those present in either affinity chromatography ligands or leashes, e.g. ethylenediamine or 6-aminohexanoic acid. If butylamine was attached via the 1,1'-carbonyldiimidazole method, the resulting product was devoid of charged groups and thus had the same titration curve as agarose. The suitability of this new matrix for affinity chromatography was demonstrated by the successful purification of trypsin by several different systems.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
L. Strindelius, L. D. Wikingsson, and I. Sjoholm
Extracellular Antigens from Salmonella enteritidis Induce Effective Immune Response in Mice after Oral Vaccination
Infect. Immun., March 1, 2002; 70(3): 1434 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. F. Poletti, K. E. Bird, D. Marques, R. B. Harris, Y. Suda, and M. Sobel
Structural Aspects of Heparin Responsible for Interactions With von Willebrand Factor
Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 925 - 931.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. J. Kridel, W. W. Chan, and D. J. Knauer
Requirement of Lysine Residues Outside of the Proposed Pentasaccharide Binding Region for High Affinity Heparin Binding and Activation of Human Antithrombin III
J. Biol. Chem., August 23, 1996; 271(34): 20935 - 20941.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Sobel, K. E. Bird, R. Tyler-Cross, D. Marques, N. Toma, H. Edward Conrad, and R. B. Harris
Heparins Designed to Specifically Inhibit Platelet Interactions With von Willebrand Factor
Circulation, March 1, 1996; 93(5): 992 - 999.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1979 by the American Society for Biochemistry and Molecular Biology.